1. Evaluation of the Effects of an Undenatured Collagen Type-2-Based Nutraceutical (ARTHROSHINE ® HA²) on Recovery Time after TPLO in Dogs: A Prospective, Randomized Study with Objective Gait Analysis as the Primary Outcome Measure.
- Author
-
Assies, Maria, Berger, Björn, Stegen, Bente, Rohwedder, Thomas, Doherr, Marcus, and Böttcher, Peter
- Subjects
ANTERIOR cruciate ligament ,GAIT in humans ,OSTEOARTHRITIS ,GAIT in animals ,COLLAGEN ,LIGAMENT injuries ,FRANKFURTER sausages - Abstract
Simple Summary: Undenatured collagen type 2 is considered a promising treatment for osteoarthritis in both humans and animals. Osteoarthritis, a degenerative joint disease, is often associated with cranial cruciate ligament rupture in dogs, which frequently necessitates Tibial Plateau Leveling Osteotomy (TPLO). Despite the generally successful outcomes of TPLO, dogs frequently experience postoperative pain and ongoing joint degeneration. To address these concerns, our study delved into the effects of oral supplementation with a high-concentration undenatured collagen type 2 dietary supplement (ARTHROSHINE
® HA²) post-TPLO surgery. Employing a prospective, randomized design, we utilized treadmill analysis and a validated owner questionnaire to objectively gauge the nutraceutical supplement's influence on limb function, overall activity level, and pain. The results are highly encouraging. Gait analysis revealed a significant reduction in the duration of postoperative rehabilitation, enabling complete recovery within just 12 weeks after the procedure, compared to the 24 weeks required without the supplement. This research underscores the potential of undenatured collagen type 2 as an adjunctive therapy for alleviating lameness following TPLO surgery. Notably, subjective owner perceptions did not differ between the groups. This randomized, prospective clinical trial investigates the impact of a novel undenatured collagen type 2 (T2NDC)-based nutraceutical, ARTHROSHINE® HA² (AS), on postoperative rehabilitation following Tibial Plateau Leveling Osteotomy (TPLO) in 50 dogs with unilateral cranial cruciate ligament rupture (CCLR). The patients were randomly allocated to either group A, receiving AS once daily for 24 weeks post-TPLO surgery, or group B, without any supplementation. Frequency matching was applied to enhance group comparability. Assessment of outcomes included computerized gait analysis and a validated owner questionnaire. AS supplementation was well received, without any reported side effect. Consistently, patients in group A exhibited significantly higher peak vertical force values during all follow-up assessments. By the 12-week mark, gait analysis indicated a return to a physiological gait pattern in group A, while group B achieved this normalization only by the 24-week point. The administration of AS post-TPLO surgery demonstrates promise in enhancing limb function, leading to faster restoration of a physiological gait pattern. The inclusion of AS, a T2NDC-based nutraceutical, in the post-TPLO rehabilitation protocol may contribute to improved limb function and an expedited recovery, potentially facilitating a quicker return to normalcy. It is noteworthy that subjective owner perceptions did not differ between the two groups. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF